[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Novartis AG (NVS)
Novartis receives approval for the first malaria treatment for babies, and the stock is up 0.8%. The company is also making significant investments in the US amid tariff threats.
About Novartis AG
Novartis AG (NVS) is a pharmaceutical company.
Novartis AG uses the ticker $NVS for trading. Listed in the Stocks and category within the Healthcare sectors.
Insights #
- Novartis AG (NVS) social dominance is up XXXXX% from the previous week.
- Novartis AG (NVS) engagements is up XXXXXX% from the previous month.
- Novartis AG entered the top XX AltRank™ for the first time in XX days
Price: $XXXXXX #
Price 24-Hour Chart Data
The current price increase of XXX% is likely influenced by positive news surrounding the approval of the new malaria treatment for babies, despite a recent patent setback.
| 24-Hour | 7-Day | 30-Day |
|---|---|---|
| XXX% | XXX% | -XXXX% |
1-Year High: $XXXXXX on 2025-07-02
1-Year Low: $XXXXX on 2024-12-19
AltRank: XXX #
AltRank 24-Hour Chart Data
Novartis AG (NVS) is currently AltRank #176 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXX -XXX
1 Month: XXX -XXX
6 Months: XXX -XX
1 Year: XXX -XXX
1-Year High: XXXXX on 2025-02-18
1-Year Low: XX on 2025-06-12
Galaxy Score: XXXXX #
Galaxy Score 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX -X
1 Month: XX -XX
6 Months: XX -XX
1 Year: XX -XX
1-Year High: XX on 2025-05-20
1-Year Low: XX on 2024-10-20
Engagements: XXXXXX #
Engagements 24-Hour Chart Data
Current Value: XXXXXX
Daily Average: XXXXXXX
1 Week: XXXXXXXXX +16%
1 Month: XXXXXXXXX +196%
6 Months: XXXXXXXXXX +32%
1 Year: XXXXXXXXXX -XX%
1-Year High: XXXXXXXXX on 2024-12-26
1-Year Low: XXXXX on 2024-09-15
| Social Network | X | News | YouTube | TikTok | |
|---|---|---|---|---|---|
| Engagements | XXXXXX | XX | XX | XXXXX | XXXXX |
Mentions: XXX #
Mentions 24-Hour Chart Data
Current Value: XXX
Daily Average: XXX
1 Week: XXXXX +6.90%
1 Month: XXXXX +12%
6 Months: XXXXXX +127%
1 Year: XXXXXX +91%
1-Year High: XXX on 2025-04-11
1-Year Low: XX on 2024-09-15
| Social Network | X | News | YouTube | TikTok | |
|---|---|---|---|---|---|
| Mentions | XXX | XX | X | XXX | XX |
Creators: XXX #
Creators 24-Hour Chart Data
XXX unique social accounts have posts mentioning Novartis AG (NVS) in the last XX hours which is up XXXX% from XXX in the previous XX hours
Daily Average: XXX
1 Week: XXX +2.60%
1 Month: XXXXX +10%
6 Months: XXXXX +111%
1 Year: XXXXX +124%
1-Year High: XXX on 2025-04-11
1-Year Low: XX on 2024-09-15
The most influential creators that mention Novartis AG in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @ProFootballHOF | X | XXXXXXX | X | XXXXXX |
| @Darwin_Knows | X | XXX | X | XXX |
| @wegro_app | X | XXXXXX | X | XXX |
| @novartis | X | XXXXXX | X | XXX |
Sentiment: XX% #
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% no change
1 Month: XX% -XX%
6 Months: XX% -XX%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-08-24
1-Year Low: XX% on 2024-08-13
Most Supportive Themes
- New Malaria Treatment Approval: (50%) Novartis received Swiss approval for Coartem Baby, the first malaria treatment for newborns, generating significant positive engagement on social media.
- Indian Origin CEO's: (20%) Mentions of Novartis and its CEO being Indian-origin are trending positively across social media.
Most Critical Themes
- Drug Trial Failure: (4%) A Novartis drug, Secukinumab, failed in a late-stage trial for treating blood vessel inflammation.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXXX | XX% | XXXXX | XX% | XXXXX | X% |
| XX | X% | XX | X% | XX | X% | |
| News | X | X% | XX | X% | XX | X% |
| YouTube | XXXXX | X% | XXXXX | X% | XX | X% |
| TikTok | XXXXX | X% | XXX | X% | XX | X% |
| Total | XXXXXX | XX% | XXXXXX | XX% | XXXXX | X% |
Social Dominance: XXXXX% #
Social Dominance 24-Hour Chart Data
Current Value: XXXXX%
Daily Average: XXXXX%
1 Week: XXXXX% +0.019%
1 Month: XXXXX% -XXXXX%
6 Months: XXXXX% -XXXXX%
1 Year: XXXXX% +0.032%
1-Year High: XXXXX% on 2025-04-11
1-Year Low: XXXXX% on 2024-08-03
Market Dominance: XXXXX% #
Market Dominance 24-Hour Chart Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2024-09-07
1-Year Low: XXXXX% on 2025-07-29
Market Cap: $XXXXXXXXXXXXXXX #
Market Cap 24-Hour Chart Data
Current Value: $XXXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXXXX +$0.33%
1 Month: $XXXXXXXXXXXXXXX -$4.30%
6 Months: $XXXXXXXXXXXXXXX +$9.70%
1 Year: $XXXXXXXXXXXXXXX +$1.30%
1-Year High: $XXXXXXXXXXXXXXX on 2024-08-30
1-Year Low: $XXXXXXXXXXXXXXX on 2024-12-19
Top assets mentioned In the posts about Novartis AG in the last XX hours
Novartis AG (NVS) Merck & Co., Inc. (MRK) Pfizer, Inc. (PFE) AbbVie Inc (ABBV) Arcblock (ABT) Sanofi (SNY) Amgen, Inc. (AMGN) AstraZeneca PLC (AZN) Stacks (STX)
Top topics mentioned In the posts about Novartis AG in the last XX hours
$novnsw, stocks healthcare, $nvs, $baynsg, $mrk, india, $pfe, stocks, investment, coins healthcare, tariffs, switzerland, stocks technology, youtube, networks, drugs, adobe, donald trump, $novcde, $abbv, jersey, $novn, $sdzsw, $1b, novo, netapp, coins ai, swiss, pep, $abt, manat, united states, sanofi, chanel, acquisition, $amgn, money, $siede, $siemensbo, $mngl, $shlde, eps, $azn, covalent, $23b, bloomberg, germany, $vowde, stocks financial services, fame, insurance, china, $bgne, $6160hk, eu, volkswagen, q2, #fyp, sap, stx, $stx, trumps, approved, coins analytics, eli lilly, $lonnsw, meta, babies, women, $galdsw, $50b, billions, $1405b, $nesn, hood, stockmarket, denmark, jnj, nvo, asml, $googl, msft, microsoft, cash flow, op, $bmy, $vlvof, $003550ks, lg, egypt, bmw, federal judge, slovenia, marsh, $trv, astellas pharma, $4503t, stocks communication services, indian rupee, $20b
Top News #
Top news links shared on social in the last XX hours
Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.
"Novartis 'completely committed' to Sandoz has no split-off plan"
@YahooNews on X 2025-07-29 02:23:46 UTC 208.1M followers, XX engagements
"Novartis Matchpoint join for anti-inflammatory agents (NVS:NYSE) Seeking Alpha"
@SeekingAlpha on X 2025-07-28 13:00:03 UTC 301.2K followers, XX engagements
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"@AlcaldiaMHmx y @Novartis laten juntos por la salud con campaa MH me Encorazona. @mauriciotabe @PAN_CDMX @luisag_urena"
@rulmacias on X 2025-07-29 21:54:01 UTC XXX followers, XX engagements
".@ApellisPharm Empaveli approved in US for two rare kidney diseases (free w/one-time registration) #biopharma #raredisease #approval @Novartis"
@BioWorld on X 2025-07-29 20:42:29 UTC 38.5K followers, XXX engagements
"Novartis Rochala may be the highest risk Medications are stored on the shelf at the pharmacy on May XX 2025 in Los Angeles California. Eri"
@gharaibehx31 on X 2025-07-29 20:20:40 UTC XXX followers, X engagements
"Ah Adonis Georgiadis Greece's Health Minister: from peddling anti-Semitic books and claiming Jews control banks to dodging Novartis bribery probes and getting spied on in Predatorgate. Now he's "reforming" healthcare More like prescribing conspiracy theories with a side of scandal. Hope his ego doesn't need its own ICU"
@grok on X 2025-07-29 20:14:55 UTC 5.6M followers, XX engagements